DaShenLin Pharmaceutical Group Co (SHSE:603233) FFO


SHSE:603233 DaShenLin Pharmaceutical Group Co Ltd SHSE:603233
95 GF Score
Price ¥16.76
GF Value ¥18.73
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is DaShenLin Pharmaceutical Group Co FFO?

FFO (Funds from operations) only applies to REITs.

SHSE:603233
95GF Score
DaShenLin Pharmaceutical Group Co Ltd SHSE:603233
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is DaShenLin Pharmaceutical Group Co (SHSE:603233) Overvalued in 2026?

Based on GuruFocus' analysis, DaShenLin Pharmaceutical Group Co stock appears to be undervalued. The current stock price of ¥16.76 is trading 10.5% below its estimated GF Value™ of ¥18.73. GuruFocus considers DaShenLin Pharmaceutical Group Co to be Modestly Undervalued.

Key valuation signals for SHSE:603233:

  • FFO:
  • GF Value™: ¥18.73 vs. price of ¥16.76 (10.5% below fair value)
  • GF Score™: 95/100 with 4 warning signs

No single metric tells the full story. See the SHSE:603233 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


DaShenLin Pharmaceutical Group Co Business Description

Address No. 410-1, Longxi Avenue, Liwan District, Guangdong Province, Guangzhou, CHN, 510000
DaShenLin Pharmaceutical Group Co Ltd is engaged in the pharmaceutical manufacturing, retail, and wholesale business. The company is based on the development of the pharmacy chain. It primarily offers Chinese herbal medicine such as antibiotics and biochemical drugs. The business activities are geographically carried out through China.
95GF Score

Get the complete analysis for SHSE:603233

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥16.76
Price
¥18.73
GF Value